Moderna has begun human trials for an mRNA vaccine called mRNA-1010, that targets multiple influenza strains, the company announced Wednesday. The American pharmaceutical and biotechnology firm based in Cambridge, aims on the long run for one seasonal shot for...
A device, called SpectraLIT, uses mass spectrometry to generate high resolution spectral signatures of a sample’s contents. These signatures are interpreted using artificial intelligence as either...
Pfizer and BioNTech announced on Thursday that they were developing a version of the coronavirus vaccine that targets the Indian Delta variant, which has spread to nearly 100 countries. The U.S.-based company expects to begin clinical...
Since the previous round of research, the COVID-19 pandemic has accelerated gaming trends already in motion, leading to an expanded gaming audience and through-the-roof engagement. To...
Uber is offering sign-up bonuses and other incentives for drivers as it faces record demand for rides and meal delivery. The San Francisco ride-hailing company said...
IBM’s consumer survey released Thursday adds to the growing amount of data showing optimism as the world slowly emerges from the pandemic. The study shows that...
New York City announced earlier this week the deployment of a new COVID-19 passport built on IBM’s blockchain-based health pass technology, as businesses in the U.S....
On March 4, 2020, when there were just 84 confirmed cases of COVID-19 in the U.K., professor Sharon Peacock recognized that the country needed to expand...
Uncertainty about demand for office space in a global pandemic is a big risk that investors will have to weigh as WeWork makes a second run...
At first, many schools announced it would last only a couple weeks. A year later, the unplanned experiment with distance learning continues for thousands of students...